seek and you will find

  • Home
  • Technology
  • Products 
    • Products Overview
    • SeekInCare
    • SeekInCure
    • SeekInClarity
    • OncoSeek
    • LungCanSeek
    • OncoGate
    • LeukoPrint
    • OncoGraph
    • PanCanSeek
    • SeekInEZ
    • EGFRseek
    • PHLseek
    • SeekInJoy
    • PetCanSeek
  • Publication 
    • Research
    • Others
  • Newsroom
  • Product & Service Inquiry
  • …  
    • Home
    • Technology
    • Products 
      • Products Overview
      • SeekInCare
      • SeekInCure
      • SeekInClarity
      • OncoSeek
      • LungCanSeek
      • OncoGate
      • LeukoPrint
      • OncoGraph
      • PanCanSeek
      • SeekInEZ
      • EGFRseek
      • PHLseek
      • SeekInJoy
      • PetCanSeek
    • Publication 
      • Research
      • Others
    • Newsroom
    • Product & Service Inquiry

seek and you will find

  • Home
  • Technology
  • Products 
    • Products Overview
    • SeekInCare
    • SeekInCure
    • SeekInClarity
    • OncoSeek
    • LungCanSeek
    • OncoGate
    • LeukoPrint
    • OncoGraph
    • PanCanSeek
    • SeekInEZ
    • EGFRseek
    • PHLseek
    • SeekInJoy
    • PetCanSeek
  • Publication 
    • Research
    • Others
  • Newsroom
  • Product & Service Inquiry
  • …  
    • Home
    • Technology
    • Products 
      • Products Overview
      • SeekInCare
      • SeekInCure
      • SeekInClarity
      • OncoSeek
      • LungCanSeek
      • OncoGate
      • LeukoPrint
      • OncoGraph
      • PanCanSeek
      • SeekInEZ
      • EGFRseek
      • PHLseek
      • SeekInJoy
      • PetCanSeek
    • Publication 
      • Research
      • Others
    • Newsroom
    • Product & Service Inquiry

SeekIn Strengthens U.S. Trademark Portfolio with Registration of OncoGraph® and OncoGate®

· Press Releases

SAN DIEGO, CA – November 16, 2026 – SeekIn Inc. (“SeekIn”), a biotechnology company specializing in blood-based cancer detection and monitoring technologies, today announced that two additional trademarks, OncoGraph® and OncoGate®, have officially registered with the United States Patent and Trademark Office (USPTO).

The newly registered trademarks, bearing U.S. Trademark Registration Nos. 8,531,619 and 8,531,620, respectively, represent another milestone in SeekIn's continued efforts to strengthen its intellectual property portfolio and establish its brand presence in the United States.

These registrations further expand SeekIn's growing U.S. trademark portfolio, which already includes its key product brands: OncoSeek®, SeekInCare®, SeekInClarity®, LeukoPrint®, PanCanSeek®, and PetCanSeek®. Together, these trademarks represent SeekIn's expanding portfolio of innovative diagnostic products, technologies, and solutions across cancer detection, monitoring, and precision diagnostics.

Strengthening SeekIn's Intellectual Property and Brand Portfolio

Trademarks play an important role in protecting a company's brand identity, supporting commercial development, and building long-term market recognition. By securing trademark registrations for its major products and technology platforms in the United States, SeekIn continues to reinforce its commitment to protecting its intellectual property and maintaining a consistent global brand strategy.

The addition of OncoGraph® and OncoGate® reflects SeekIn's ongoing innovation and expanding technology portfolio, further consolidating its position in the rapidly evolving cancer diagnostics industry.

Commitment to Innovation and Global Expansion

SeekIn remains committed to advancing innovative, accessible, and data-driven cancer diagnostic technologies. With an increasingly comprehensive trademark portfolio in the United States, the company is well positioned to support the continued development, commercialization, and international expansion of its diagnostic solutions.

"Building a strong intellectual property portfolio is an important part of our long-term strategy," said Ms. Shujia Hao, Co-founder & CFO of SeekIn Inc. "The registration of OncoGraph and OncoGate, together with our previously registered product trademarks, reflects our commitment to protecting our innovations, strengthening our global brands, and advancing our mission to make cancer diagnostics more accessible."

Previous
xTenure and SeekIn Announce Strategic Partnership to...
 Return to site
Cookie Use
We use cookies to improve browsing experience, security, and data collection. By accepting, you agree to the use of cookies for advertising and analytics. You can change your cookie settings at any time. Learn More
Accept all
Settings
Decline All
Cookie Settings
These cookies enable core functionality such as security, network management, and accessibility. These cookies can’t be switched off.
These cookies help us better understand how visitors interact with our website and help us discover errors.
These cookies allow the website to remember choices you've made to provide enhanced functionality and personalization.
Save